{
  "id": [
    "28979794"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "28979794"
  ],
  "pmcid": [
    "PMC5617092"
  ],
  "doi": [
    "10.1177/2055217317723369"
  ],
  "title": [
    "Disease-modifying therapies in multiple sclerosis in Latin America."
  ],
  "authorString": [
    "Skromne-Eisenberg E, Ordoñez-Boschetti L, Treviño-Frenk I."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Skromne-Eisenberg E"
          ],
          "firstName": [
            "Eli"
          ],
          "lastName": [
            "Skromne-Eisenberg"
          ],
          "initials": [
            "E"
          ],
          "affiliation": [
            "Instituto Mexicano de Neurociencias, Hospital Ángeles Lomas, Mexico."
          ]
        },
        {
          "fullName": [
            "Ordoñez-Boschetti L"
          ],
          "firstName": [
            "Laura"
          ],
          "lastName": [
            "Ordoñez-Boschetti"
          ],
          "initials": [
            "L"
          ],
          "affiliation": [
            "Mexican Committee for Treatment and Research in Multiple Sclerosis (MEXCTRIMS), Mexico."
          ]
        },
        {
          "fullName": [
            "Treviño-Frenk I"
          ],
          "firstName": [
            "Irene"
          ],
          "lastName": [
            "Treviño-Frenk"
          ],
          "initials": [
            "I"
          ],
          "affiliation": [
            "Instituto Nacional de Ciencias Médicas y Nutrición \"Salvador Zubirán\", Mexico."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "3"
      ],
      "volume": [
        "3"
      ],
      "journalIssueId": [
        "2589736"
      ],
      "dateOfPublication": [
        "2017 Jul-Sep"
      ],
      "monthOfPublication": [
        "0"
      ],
      "yearOfPublication": [
        "2017"
      ],
      "printPublicationDate": [
        "2017-07-01"
      ],
      "journal": [
        {
          "title": [
            "Multiple sclerosis journal - experimental, translational and clinical"
          ],
          "ISOAbbreviation": [
            "Mult Scler J Exp Transl Clin"
          ],
          "medlineAbbreviation": [
            "Mult Scler J Exp Transl Clin"
          ],
          "NLMid": [
            "101668877"
          ],
          "ISSN": [
            "2055-2173"
          ],
          "ESSN": [
            "2055-2173"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2017"
  ],
  "pageInfo": [
    "2055217317723369"
  ],
  "abstractText": [
    "The treatment of multiple sclerosis (MS) has become increasingly complex during the last 10 years, mainly because of the advent of new and more potent disease-modifying therapies (DMTs). In Latin America, the therapeutic repertoire available for MS treatment is similar to the one in the rest of the world, but the high costs of these drugs, in conjunction with the limited resources of the social security health systems, makes the treatment of MS more difficult. For neurologists in Latin America, providing personalized MS treatment has become a challenge. We present a review of the status of the DMT in Central and South America, benefits as well as limitations for providing full access to these medications in Latin America."
  ],
  "affiliation": [
    "Instituto Mexicano de Neurociencias, Hospital Ángeles Lomas, Mexico."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic-eCollection"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Treatment Response",
        "Disease-modifying Therapies",
        "Second-line Treatment"
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5617092?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5617092"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1177/2055217317723369"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by-nc"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCreation": [
    "2017-10-05"
  ],
  "dateOfRevision": [
    "2017-10-08"
  ],
  "electronicPublicationDate": [
    "2017-09-25"
  ],
  "firstPublicationDate": [
    "2017-07-01"
  ]
}